Search Thermo Fisher Scientific
Let’s suppose you use qPCR to determine the expression of oncogenes or tumor suppressor genes in a tumor biopsy sample. These clinical samples are difficult to collect and generally only contain a small amount of usable mRNA.
In a singleplex relative quantification experiment, only one gene—either the gene of interest or the control—is amplified in each well. Assuming that each assay is performed in triplicate, you will need to divide your sample into six wells (three for the test gene and three for the endogenous control) to measure the expression of a single gene. Thus, the number of genes that can be tested using the limited amount of biopsy sample will be restricted by running singleplex reactions for each gene. However, these limitations can be overcome by amplifying the 2 genes (or multiple genes) in the same reaction.
In multiplexing, you can reduce the amount of sample required for a qPCR reaction by measuring the expression of more than one gene in a reaction. The process is as sensitive and accurate as single-gene amplification (or singleplexing), but more technically complex [1].
In addition to conserving the amount of valuable sample, multiplexing also has other advantages. The first is cost reduction. If you amplify two or more genes in one well, you can save on reagents, and also on the time taken to set up experiments and analyze results. Secondly, amplification of multiple genes in the same wells improves precision by minimizing pipetting errors. If the genes to be compared are amplified in the same wells, small differences in sample and reagent amounts in each well will not cause problems.
The simplest, and most commonly used, type of multiplexing is duplexing, in which two genes are amplified in a single reaction. Typically, in a relative qPCR experiment designed to determine the fold change differences in gene expression, these will be a single gene of interest (target gene) and an endogenous control. TaqMan assays to detect the target and control genes, containing probes that have been labeled with 2 distinct fluorescent dyes, are added to the same reaction, and use the same pool of Taq polymerase enzymes, nucleotides, and other reagents during amplification.
The real time PCR instrument used for performing amplification must be capable of distinguishing precisely between these fluorescent labels and measuring the signals produced by the amplification of each gene. Typically, the probe for your gene of interest is labeled with FAM dye and the probe for the control with VIC dye. The emission spectra for FAM and VIC peak at 517nm (in the blue region of the visible spectrum) and 551nm (in the green region) respectively (Figure 1), making these wavelengths easily distinguishable by any Applied Biosystems real time PCR instrument.
You can, under carefully optimized conditions, perform multiplex qPCR to measure the expression of three or four genes simultaneously in a reaction. This can provide huge savings in cost, reagents and time, but the resulting experiments are more complex, and validation becomes more time-consuming. When interrogating 3 or 4 targets in the same well, there is even more competition for shared reagents than in a duplex reaction, and the scope for unwanted interactions between primers and probes increases. Thus it is necessary to validate the multiplex reaction thoroughly following the same guidelines outlined above for performing a duplex reaction.
In a multiplex reaction with 2 or more targets, you can utilize TaqMan assays for the genes of interest, with each assay probe labeled with a different dye. Applied Biosystems range of dyes now also includes ABY and JUN, with fluorescence spectra that peak at 580 nm (yellow) and 617 nm (orange-red) respectively and can be used in conjunction with FAM and VIC dyes.
The TaqMan quencher, QSY, is available for optimal high-level multiplexing with best performance in 3 and 4-plex reactions. Similar to the MGB-NFQ quenchers, QSY is a non-fluorescent quencher, however the QSY probes don’t have a MGB moiety. If for example, you are running a 4-plex reaction, two TaqMan assays can be FAM and VIC probes labeled with an MGB-NFQ quencher while the other two assays should have ABY and JUN labeled probes with a QSY quencher.
Important considerations when optimizing multiplex assays include:
The many advantages of multiplex qPCR experiments arise from the fact that the assays for the test and the control gene use the same reagents in the same reaction. These reactions are, however, in competition for the same limited pool of reagents. This could cause problems when one gene (most often the control) is much more abundant than the other gene(s) in the sample. In this case, the highly expressed gene will start amplification earlier in the run than the less abundant gene(s), and may even reach its linear and plateau phases before the less abundant gene(s) has started amplification. The amplification of the first gene may thus use up most of the nucleotides and other reagents in the pool. This leaves the remaining genes without enough reagents to amplify properly, and the Ct value recorded will not reflect actual abundance.
Fortunately, this problem has a simple solution: primer limitation, which involves running the assay for the more abundant gene with strictly limited primer amounts. Under these circumstances, that gene will reach its plateau more quickly due to running out of primers, and not due to the lack of reagents, which are in excess. There should be enough nucleotides, polymerase and other reagents left for the amplification of the less abundant genes. In a primer limited multiplex reaction, the Ct values for both genes will still be measured accurately.
In a typical singleplex TaqMan reaction the primer concentrations are 900nM each and the probe has a concentration of 250nM. In a primer limited assay, the primers are typically reduced to 150nM each with the probe concentrations remaining unchanged.
Multiplexing will not always be appropriate for your qPCR experiments. Before you embark on a multiplex experiment, optimize the assay conditions and validate them carefully.
Confirm that results obtained from multiplexing are the same as results obtained from singleplex reactions. The general procedure is as follows:
Each reaction should be carried out in triplicate
As multiplexing minimizes pipetting errors, you might assume that by using this technique, you guarantee low variation in Ct values between replicates. This is not always the case, as variation can arise from interactions between the complex mix of reagents in the well. If the variation between replicates is high, you can try to increase precision by increasing the number of replicates, though this will reduce your reagent and cost savings. Widely varying results suggest you should return to singleplexing.
Figure 1: Fluorescence emission spectra of different dyes used for multiplex qPCR.
For Research Use Only. Not for use in diagnostic procedures.